Phosphatidylserine-based liposomes encapsulating DMX-5804 protect against doxorubicin-induced cardiotoxicity

RSC Pharmaceutics 2026 Open access

Read full text
Authors: Jessica Tetterton-Kellner, Audreanna Miserendino, Imran Tariq, Brian C. Jensen, Juliane Nguyen
DOI: 10.1039/d6pm00059b
Cited by: 0

Abstract

Heart damage caused by anthracycline chemotherapy is a major concern for cancer patients and their doctors. This toxicity may be reduced by NanoDMX, a liposomal formulation of the drug DMX5804.

Fields of Study & Subjects

Chemotherapy-induced cardiotoxicity and mitigation Nanoparticle-Based Drug Delivery Cancer therapeutics and mechanisms

Publication details

Journal / source
RSC Pharmaceutics
Publication date
1 January 2026
Language
EN